| Vitamin D and its potential interplay with pain signaling pathways AM Habib, K Nagi, B Nagendra, V Thillaiappan, S Akhtar Frontiers in Immunology 11, 820, 2020 | 72 | 2020 |
| Kir3 channel signaling complexes: focus on opioid receptor signaling K Nagi, G Pineyro Frontiers in Cellular Neuroscience 8, 186, 2014 | 67 | 2014 |
| Regulation of opioid receptor signalling: implications for the development of analgesic tolerance K Nagi, G Piñeyro Molecular Brain 4 (1), 25, 2011 | 62 | 2011 |
| Conformational dynamics of Kir3. 1/Kir3. 2 channel activation via δ-opioid receptors M Richard-Lalonde, K Nagi, N Audet, R Sleno, M Amraei, M Hogue, ... Molecular Pharmacology 83 (2), 416-428, 2013 | 58 | 2013 |
| Ligand-and cell-dependent determinants of internalization and cAMP modulation by delta opioid receptor (DOR) agonists I Charfi, K Nagi, O Mnie-Filali, D Thibault, G Balboni, PW Schiller, ... Cellular and Molecular Life Sciences 71 (8), 1529-1546, 2014 | 43 | 2014 |
| Exploring use of unsupervised clustering to associate signaling profiles of GPCR ligands to clinical response B Benredjem, J Gallion, D Pelletier, P Dallaire, J Charbonneau, D Cawkill, ... Nature Communications 10 (1), 1-15, 2019 | 32 | 2019 |
| Practical guide for calculating and representing biased signaling by GPCR ligands: A stepwise approach K Nagi, G Pineyro Methods 92, 78-86, 2016 | 31 | 2016 |
| Signaling diversity of mu-and delta-opioid receptor ligands: Re-evaluating the benefits of β-arrestin/G protein signaling bias G Pineyro, K Nagi Cellular Signalling 80, 109906, 2021 | 24 | 2021 |
| Activation of Kv7 channels with the anticonvulsant retigabine alleviates neuropathic pain behaviour in the streptozotocin rat model of diabetic neuropathy L Djouhri, MI Malki, A Zeidan, K Nagi, T Smith Journal of Drug Targeting, 1-9, 2019 | 24 | 2019 |
| Kir3 channels undergo arrestin-dependant internalization following delta opioid receptor activation K Nagi, I Charfi, G Pineyro Cellular and Molecular Life Sciences 72 (18), 3543-3557, 2015 | 21 | 2015 |
| High-risk human papillomaviruses and Epstein–Barr virus in breast cancer in Lebanese women and their association with tumor grade: a molecular and tissue microarray study K Nagi, I Gupta, N Jurdi, A Jabeen, A Yasmeen, G Batist, S Vranic, ... Cancer Cell International 21 (1), 308, 2021 | 19 | 2021 |
| Interleukin-9 mediates chronic kidney disease-dependent vein graft disease: a role for mast cells L Zhang, JH Wu, JC Otto, SB Gurley, ER Hauser, SK Shenoy, K Nagi, ... Cardiovascular Research 113 (13), 1551-1559, 2017 | 18 | 2017 |
| Design and construction of conformational biosensors to monitor ion channel activation: a prototype FlAsH/BRET-approach to Kir3 channels DN Robertson, R Sleno, K Nagi, D Pétrin, TE Hébert, G Pineyro Methods 92, 19-35, 2016 | 14 | 2016 |
| Copresence of high-risk human papillomaviruses and Epstein–Barr Virus in colorectal cancer: a tissue microarray and molecular study from Lebanon K Nagi, I Gupta, N Jurdi, A Yasmeen, S Vranic, G Batist, AEA Moustafa International Journal of Molecular Sciences 22 (15), 8118, 2021 | 11 | 2021 |
| Encoding the β-arrestin Trafficking Fate of the Ghrelin Receptor GHSR1a: C-tail Independent Molecular Determinants in GPCRs K Toth, K Nagi, LM Slosky, L Rochelle, C Ray, S Kaur, SK Shenoy, ... ACS Pharmacology & Translational Science, 2019 | 8 | 2019 |
| Biased signaling: A viable strategy to drug ghrelin receptors for the treatment of obesity K Nagi, AM Habib Cellular Signalling 83, 109976, 2021 | 7 | 2021 |
| Molecular aspects of delta opioid receptors L Gendron, K Nagi, M Zeghal, PM Giguère, G Pineyro Vitamins and Hormones, 2019 | 7 | 2019 |
| In-frame fusion of SUMO1 enhances βarrestin2's association with activated GPCRs as well as with nuclear pore complexes K Nagi, S Kaur, Y Bai, SK Shenoy Cellular Signalling 75, 109759, 2020 | 6 | 2020 |
| Comprehensive Signaling Profiles Reveal Unsuspected Functional Selectivity of δ-Opioid Receptor Agonists and Allow the Identification of Ligands with the Greatest Potential for … A Mansour, K Nagi, P Dallaire, V Lukasheva, C Le Gouill, M Bouvier, ... ACS Pharmacology & Translational Science 4 (5), 1483-1498, 2021 | 5 | 2021 |
| Biased agonism at G protein-coupled receptors K Nagi, HO Onaran Cellular Signalling 83, 109981, 2021 | 5 | 2021 |
Michel BouvierProfessor of Biochem. and Mol. Med., IRIC, Univ. de MontréalVerified email at umontreal.ca
